{"id":"W4386445019","doi":"10.1016/j.annonc.2023.08.011","title":"Pooled ctDNA analysis of MONALEESA phase III advanced breast cancer trials","year":2023,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"Novartis Pharmaceuticals Corporation; Novartis","keywords":"Medicine; Oncology; CDKN2A; Internal medicine; Breast cancer; Clinical trial; Cancer; Palbociclib; Biomarker; Progression-free survival; Placebo; Metastatic breast cancer; Pathology; Overall survival; Genetics; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001124551,0.0002055315,0.002341237,0.0008847318,0.00003554488,0.000002226201,0.0001684655,0.0001597574,0.001399156],"category_scores_gemma":[0.0003061303,0.0001736538,0.0006152865,0.002323533,0.0002470073,0.000105513,0.00005818189,0.0001488729,0.00001343416],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007140097,"about_ca_system_score_gemma":0.0004117965,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001951527,"about_ca_topic_score_gemma":0.000130931,"domain_scores_codex":[0.997612,0.0002134636,0.001094469,0.0003430928,0.000338168,0.0003988209],"domain_scores_gemma":[0.9972306,0.0006535652,0.0008845429,0.000428665,0.0006409203,0.0001616976],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.01275596,0.0008596958,0.002359917,0.0001008632,0.009805162,0.00006356699,0.0007042644,0.002235409,0.1596131,0.0002517254,0.001557991,0.8096924],"study_design_scores_gemma":[0.1104434,0.01179282,0.3226848,0.0007973259,0.02647879,0.0001675507,0.00388199,0.005093062,0.2806086,0.003300392,0.2333901,0.001361101],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9806907,0.002187682,0.0002431475,0.01422905,0.0002779886,0.0005146044,0.0008049851,0.00009322303,0.0009586388],"genre_scores_gemma":[0.9949136,0.002105489,0.0003544998,0.001418563,0.0001799988,0.000121514,0.000127503,0.00002922094,0.0007496218],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8083313,"threshold_uncertainty_score":0.9995137,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1426327814807415,"score_gpt":0.499450519089931,"score_spread":0.3568177376091896,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}